Skip to main content
logo
TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.250
-0.280 (-7.93%)
Nov 6, 2026, 4:00 PM EST - Market closed

TriSalus Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
200349153222313309
Market Cap Growth
-9.82%128.28%-31.30%-29.05%1.52%-
Enterprise Value
188360165203--
Last Close Price
3.256.985.018.4510.039.88

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
4.447.725.1912.0125.2836.75
PB Ratio
30.50-10.30-5.90-8.22-25.439.99

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
4.187.985.6010.95--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
5.26-1.02-0.91-0.06-0.16-
Net Debt / Equity Ratio
-1.81-0.41-0.580.380.61-0.98
Net Debt / EBITDA Ratio
0.40-0.53-0.430.210.211.29
Net Debt / FCF Ratio
0.51-0.74-0.370.200.231.27
Asset Turnover
0.871.521.210.800.410.37
Inventory Turnover
1.601.961.251.301.631.28
Quick Ratio
4.722.351.331.040.344.97
Current Ratio
5.352.802.021.420.535.51
Return on Equity (ROE)
-----507.96%-
Return on Assets (ROA)
-36.75%-56.80%-93.08%-134.61%-76.13%-65.35%
Return on Capital Employed (ROCE)
-59.50%-113.10%-263.20%-506.30%351.70%-76.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-35.33%-11.25%-19.67%-26.70%-15.05%-9.34%
FCF Yield
-11.63%-5.43%-26.96%-23.01%-10.52%-7.71%
Buyback Yield / Dilution
-73.15%-49.61%-169.61%-2934.71%96.51%-15.52%
SEC Filings: 10-K · 10-Q